GLP-1 agonists mimic the GLP-1 hormone in the gut, prompting the pancreas to release more insulin after meals, improving insulin sensitivity, reducing liver glucose production, and slowing digestion for steadier blood sugar levels
While lifestyle changes are foundational, new pharmacological therapies are transforming outcomes, particularly the class of medications known as incretin mimetics
Risk of Aborted Procedures and the Need to Repeat As a result of the increased risk of RGC with GLP-1 RAs and the subsequent increase in the risk of limited visibility and peri-procedural aspiration, the use of these agents can result in aborted procedures and the need to repeat for better visualization
Our reviewer found it very easy to cancel their Factor subscription
Focus On Nutrient-Dense Whole Foods As your food intake should decrease, nutrition for people taking GLP-1 medications has a lot in common with other recommended meal plans